These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12240882)

  • 1. Barriers to antiretroviral adherence among HIV-infected adults.
    Murphy DA; Roberts KJ; Martin DJ; Marelich W; Hoffman D
    AIDS Patient Care STDS; 2000 Jan; 14(1):47-58. PubMed ID: 12240882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients.
    Murphy DA; Roberts KJ; Hoffman D; Molina A; Lu MC
    AIDS Care; 2003 Apr; 15(2):217-30. PubMed ID: 12856343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.
    Proctor VE; Tesfa A; Tompkins DC
    AIDS Patient Care STDS; 1999 Sep; 13(9):535-44. PubMed ID: 10813033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of antiretroviral adherence.
    Murphy DA; Marelich WD; Hoffman D; Steers WN
    AIDS Care; 2004 May; 16(4):471-84. PubMed ID: 15203415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV patient insight on adhering to medication: a qualitative analysis.
    Beusterien KM; Davis EA; Flood R; Howard K; Jordan J
    AIDS Care; 2008 Feb; 20(2):244-52. PubMed ID: 18293136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
    Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
    Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vets, denialists and rememberers: social typologies of patient adherence and non-adherence to HAART from the perspective of HIV care providers.
    Orchard T; Salters K; Palmer A; Michelow W; Lepik KJ; Hogg R
    AIDS Care; 2015; 27(6):758-61. PubMed ID: 25635938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supporting adherence to highly active antiretroviral therapy and protected sex among people living with HIV/AIDS: the role of patient-provider communication in Rio de Janeiro, Brazil.
    Fehringer J; Bastos FI; Massard E; Maia L; Pilotto JH; Kerrigan D
    AIDS Patient Care STDS; 2006 Sep; 20(9):637-48. PubMed ID: 16987050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to HAART regimens.
    Chesney M
    AIDS Patient Care STDS; 2003 Apr; 17(4):169-77. PubMed ID: 12737640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to antiretroviral medication adherence in HIV-infected women.
    Roberts KJ; Mann T
    AIDS Care; 2000 Aug; 12(4):377-86. PubMed ID: 11091770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons.
    Power R; Koopman C; Volk J; Israelski DM; Stone L; Chesney MA; Spiegel D
    AIDS Patient Care STDS; 2003 May; 17(5):245-52. PubMed ID: 12816618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative assessments of HAART adherence of substance-abusing women.
    Powell-Cope GM; White J; Henkelman EJ; Turner BJ
    AIDS Care; 2003 Apr; 15(2):239-49. PubMed ID: 12856345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: lessons learned from Project HEART.
    Davies G; Koenig LJ; Stratford D; Palmore M; Bush T; Golde M; Malatino E; Todd-Turner M; Ellerbrock TV
    AIDS Care; 2006 Nov; 18(8):895-903. PubMed ID: 17012078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors associated with adherence to therapy among HIV-infected patients in Bangui].
    Mouala C; Kaba-Mebri J; Wata JB; Rey JL
    Sante; 2006; 16(2):119-30. PubMed ID: 17116636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the HIV/AIDS case manager: analysis of a case management adherence training and coordination program in North Carolina.
    Shelton RC; Golin CE; Smith SR; Eng E; Kaplan A
    AIDS Patient Care STDS; 2006 Mar; 20(3):193-204. PubMed ID: 16548716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stigma and social barriers to medication adherence with urban youth living with HIV.
    Rao D; Kekwaletswe TC; Hosek S; Martinez J; Rodriguez F
    AIDS Care; 2007 Jan; 19(1):28-33. PubMed ID: 17129855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.